Deep impact of COVID-19 in the healthcare of Latin America: the case of Brazil
AUTOR(ES)
Cimerman, Sergio; Chebabo, Alberto; Cunha, Clovis Arns da; Rodríguez-Morales, Alfonso J.
FONTE
Braz J Infect Dis
DATA DE PUBLICAÇÃO
2020-04
RESUMO
ABSTRACT Background: Latent HIV-1 is a major hurdle in obtaining HIV-1 sustained virological remission (SVR). Here we explored histone deacetylation inhibition property of nicotinamide (NAM; n = 17) for the first time in comparison to a combination of methyltransferase inhibitors (MTIs; Chaetocin and BIX01294; n = 25) to reactivate latent HIV ex vivo in CD8-depleted PBMCs from antiretroviral treated aviremic individuals. Results: NAM reactivated HIV-1 from 13/17 (76.4%) samples compared to 20/25 (80.0%) using MTIs with mean viral load (VLs) of 4.32 and 3.22 log10 RNA copies/mL, respectively (p = 0.004). Mean purging time after NAM and MTIs stimulation was 5.1 and 6.75 days, respectively (p = 0.73). Viral purging in autologous cultures exhibited blunted HIV recovery with fluctuating VLs followed by a complete viral extinction when expanded in allogenic system. Electron microscopy from five supernatants revealed anomalous viral particles, with lack of complete viral genomes when characterized by ultradeep sequencing through metagenomics approach (n = 4). Conclusion: NAM alone was more potent HIV-1 activator than combination of MTIs, with potential of clinical use.
Documentos Relacionados
- Impact and future of telemedicine amidst the COVID-19 pandemic: a systematic review of the state-of-the-art in Latin America
- The impact of COVID-19 in children and adolescents with obesity in Brazil
- The impact of Chagas disease control in Latin America: a review
- Differential impact on suicide mortality during the COVID-19 pandemic in Brazil
- Impact of COVID-19 in Female Urology